微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -21.15% | -24.41% | -40.07% | 141/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -15.1% | -33.27% | -133.02% | 141/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -6.48% | 2% | 74.77% | 138/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -25.68% | -43.46% | -51.06% | 137/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -17% | -42.26% | -50.04% | 145/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -11.33% | -38.51% | 36.7% | 142/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | -17.9% | 14.64% | -49.79% | 132/158 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | -11.95% | 13.66% | -46.09% | 133/158 | 2.35% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | -8.18% | 44.62% | 60.99% | 133/158 | 1.47% | 拓新药业 | 20.51% | 行业排名> |
| 2022-12-31 | -20.97% | 90.46% | -51.52% | 133/158 | 0.72% | 拓新药业 | 19.87% | 行业排名> |
| 2022-09-30 | -13.84% | 88.42% | 6.3% | 133/158 | 2.84% | 拓新药业 | 19.91% | 行业排名> |
| 2022-06-30 | -14.77% | 76.47% | 93.28% | 141/158 | 2.19% | 小方制药 | 55.57% | 行业排名> |
| 2021-12-31 | -219.9% | -87.66% | -84.05% | 147/158 | 0.79% | 福元医药 | 25.41% | 行业排名> |
| 2021-09-30 | -119.48% | 69.22% | -90.38% | 132/158 | 4.44% | 小方制药 | 34.81% | 行业排名> |
| 2021-06-30 | -62.76% | 2% | 46.44% | 140/158 | 2.97% | 退市金泰 | 10.74% | 行业排名> |
| 2020-12-31 | -117.18% | 2% | 69.81% | 142/158 | 3.66% | ST人福 | 6.82% | 行业排名> |
| 2020-09-30 | -388.16% | 2% | 2% | 116/158 | 3.07% | 小方制药 | 71.99% | 行业排名> |